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Isolation of varicella zoster virus from the synovial 
fluid of a patient with herpes zoster arthritis 
Only a few cases of herpes zoster-associated arthri- 
tis have been reported to date (1-3). This form of arthritis is 
presumed to be viral in origin. Isolation of varicella zoster 
virus (VZV) by culture from synovial fluid has not been 
previously documented. VZV infection of the joint space 
associated with acute arthritis has been evidenced only 
once, by the finding of VZV antigen in the joint fluid (1). 
However, VZV has been isolated from the joint fluid of 
several children with chickenpox-associated arthritis ( 4 3 .  
We report herein the first case of documented isolation of 
VZV from synovial fluid in an adult with zoster-associated 
arthritis. 
A 67-year-old man presented with a warm, swollen, 
painful right knee associated with an erythematous rash with 
grouped vesicles over the L5 dermatome. Symptoms had 
begun 3 days earlier without fever. Aspiration of synovial 
fluid 4 days after the onset of arthritis symptoms yielded 40 
ml of straw-colored fluid. The synovial fluid leukocyte count 
was 17,600/mm3, with 44% lymphocytes and 56% polymor- 
phonuclear cells. Findings on blood and synovial bacterio- 
logic cultures were negative. The blood leukocyte count was 
4,400/mm3, and the erythrocyte sedimentation rate was 5 
mdhour .  
The aspirated joint fluid was immediately inoculated 
onto a culture plate of human fibroblast cells. A typical 
cytopathic effect was demonstrated 10 days after the inocu- 
lation. The tentative identification of VZV was confirmed by 
immunofluorescence staining using a specific monoclonal 
antibody (clone 2013; Biosoft, Paris, France). The serum 
VZV antibody titer as determined by enzyme-linked 
immunosorbent assay (Behring, Marburg, Germany) was 
> 15,120. The symptoms resolved spontaneously within 72 
hours, without sequelae. 
Arthritis caused by direct viral infection in the joint 
space is seldom documented. Rubella virus (6), vaccinia 
virus (7), herpes simplex virus (8), cytomegalovirus (8), 
echovirus (9), and VZV in association with chickenpox (43) 
have been cultured from the synovial fluid of patients with 
acute arthritis. Isolation of VZV from the joint fluid of our 
patient with herpes zoster eruption, in the absence of a 
bacterial pathogen, is strong presumptive evidence that the 
virus caused the arthritis. In previously reported cases of 
herpes zoster-associated arthritis (1-3), the arthritis in- 
volved one large joint (knee, hip). In 2 cases (2,3) it began 2 
or 3 days before the onset of the typical vesicular rash, and 
the skin rash and joint pain resolved completely without 
treatment within 8-10 days. The leukocyte counts in aspi- 
rated joint fluid were low, ranging from 2,000 to 9,000/mm3 
(1).  To our knowledge, findings on viral cultures were always 
negative. 
Our ability to isolate VZV from the joint fluid in this 
case, confirming the diagnosis, was probably due to early 
sampling and immediate inoculation of the fluid into culture 
cells. However, we again isolated the virus when the joint 
fluid, which had been frozen and stored at -80°C for 5 days, 
was reexamined. In view of the lack of reports of isolation of 
VZV from synovial fluid, efforts were made to confirm the 
identity of the cytopathic agent. It was indeed identified as 
VZV, not only by the characteristic cytopathic effect, but by 
positive immunofluorescence staining using a monoclonal 
antibody. 
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Arthroscopy in rheumatology training programs 
associated with NIH multipurpose arthritis centers: 
results from a survey of program directors 
Technological advances in the design of arthroscopes 
that have led to the production of much smaller units, 
applicable for use in an office setting with the patient under 
local anesthesia, have led to a rebirth of interest among 
rheumatologists in this procedure as a research and diagnos- 
tic tool. In a recent survey of American College of Rheuma- 
tology (ACR) members, one-third expressed an interest in 
taking an introductory course in arthroscopy and 194, or 
13% of the respondents, indicated an intent to start perform- 
ing arthroscopy within the next year (1). At this institution, 
one rheumatologist (RWI) has performed arthroscopy in an 
operating room setting since 1987 and has been exploring the 
role of outpatient “needle” arthroscopy for the last 2 years. 
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Several other rheumatology programs at academic medical 
centers have begun to explore possible applications of 
arthroscopy in clinical rheumatology , but the extent of 
nascent interest in the procedure is not widely appreciated. 
In order to obtain information regarding the current 
and expected future status of arthroscopy in rheumatology 
training (to be included in a presentation on this topic to the 
arthroscopy study group session at the 1992 ACR annual 
meeting), in October 1992 we asked the 14 directors of 
rheumatology training programs at institutions with active 
National Institutes of Health (NIH)-funded Multipurpose 
Arthritis and Musculoskeletal Disease Centers (MACs) to 
complete a 9-item questionnaire focusing on the current 
status of arthroscopy in the program and on views held by 
the program director regarding the future of arthroscopy in 
rheumatology. We chose to survey MAC programs because 
of their shared structure and programmatic objectives. The 
responses indicate both interest and skepticism, reflecting a 
climate in which rigorous assessment of the technique 
should occur before it is widely incorporated into the prac- 
tice of rheumatology. 
All but 1 of the program directors (13 of 14; 93%) 
completed and returned the questionnaire. The director who 
did not respond is affiliated with a program that is not active 
in arthroscopy and does not have immediate plans to enter 
the field. At least 1 member of the rheumatology faculty was 
currently performing arthroscopy at 6 of the 13 programs. 
All 6 were performing the procedure in an office setting, but 
operating room-based conventional arthroscopy was per- 
formed in only 1 program. Among the 6 active programs, 
arthroscopy was being used for research purposes in all 6, 
for diagnostic purposes in 4, and with therapeutic intent in 3. 
Of the 7 programs not currently active in arthroscopy, 2 
directors indicated that a faculty member was currently 
receiving training to perform arthroscopy, 3 indicated that 
such activity would begin within 6-12 months, and 2 indi- 
cated that a member of the rheumatology faculty would 
become involved in 1-5 years. Asked to anticipate the role of 
arthroscopy in their programs 5 years from now, 12 of the 13 
directors saw a role in research, 10 foresaw a role in 
diagnosis, and 7 anticipated a role in therapy. One director of 
a program currently active in arthroscopy thought that in 5 
years the procedure would no longer have a role. Asked to 
predict how the general rheumatology community would 
view the role of arthroscopy as a tool of the rheumatologist 
5 years from now, 11 of 13 respondents considered a 
diagnostic role, 10 a role in research, and 6 a role in therapy. 
One program director (at a center not involved in arthros- 
copy) expected that the general rheumatology community 
would see no role for arthroscopy as a tool of the rheuma- 
tologist. 
To gauge the role of arthroscopy in fellowship train- 
ing, each director was asked if fellows in their program 
currently had the opportunity to participate in arthroscopic 
procedures. Of the 6 programs active in arthroscopy, 4 
offered opportunities to participate in arthroscopy with the 
staff rheumatologist, 2 provided opportunities to perform 
arthroscopy with an orthopedist, and 2 did not offer an 
exposure to arthroscopy as part of the fellowship experi- 
ence. Of the 7 programs without a faculty arthroscopist, 3 
indicated that there was an opportunity to participate in 
arthroscopy with an orthopedist while 4 programs did not 
offer this exposure. Among the 7 programs that provided at 
least some opportunity for exposure to arthroscopy, fellows 
had taken advantage of the opportunity in 5 of the programs. 
Of the 13 program directors asked to predict the place of 
arthroscopy in rheumatology training programs 5 years from 
now, 2 considered that it would be an essential part of all 
training programs, 10 thought that the procedure would be 
offered by some training programs including their own, and 
1 stated that arthroscopy would by then not be a part of 
rheumatology fellowship training. 
Finally, the directors were asked to choose, from a 
list of 5 possibilities, the issue that they saw as the most 
significant barrier to the performance of arthroscopy by 
rheumatologists. The distribution of responses was as fol- 
lows: lack of indications for use of arthroscopy in rheuma- 
tologic situations, 6; no data from prospective clinical trials 
supporting arthroscopic intervention in any rheumatologic 
situations, 4; opposition by orthopedic surgeons, 3; financial 
issues (equipment costs, reimbursement), 2 ;  lack of training 
resources for those interested in learning the procedure, 2; 
and malpractice issues, 1. Three respondents made more 
than 1 choice. 
While the 14 medical centers with active NIH MACs 
represent only 11% of the 122 accredited training programs 
in rheumatology, each is expected to fill a leadership role in 
rheumatology research, education, and training (2 ) .  Our 
survey indicates that, as of October 1992, most MACs see 
arthroscopy as a potentially important part of their activity. 
There is a diversity of opinion regarding the role that 
arthroscopy will serve in the MACs and in general rheuma- 
tology practice. Although there is near-unanimity that ar- 
throscopy will prove valuable as a research tool, there is less 
agreement regarding its clinical role. This uncertainty may 
partly explain why exposure to arthroscopy is not yet 
integrated into fellowship training at MAC institutions, even 
at some of those that are currently active in arthroscopy. 
That this situation will change seems likely, since almost all 
program directors see arthroscopy as an important feature of 
at least some training programs in the future. 
While some MAC program directors perceive eco- 
nomic and political issues as the major barriers to further use 
of arthroscopy by the rheumatologist, the majority believe 
the procedure must await better definition of clinical indica- 
tions for its use, both in a general sense and as defined by 
prospective trials. Careful definition of the indications and 
potential benefits of arthroscopy in rheumatologic situa- 
tions-stated by Meenan as one of the 6 key issues to be 
faced by the ACR over the next 5 years (3)-can best occur 
through application of the procedure in a setting where 
rigorous ongoing analysis of these factors can take place. 
The environment of a MAC is ideally suited for this activity, 
and the research benefits of the procedure can also be made 
available to the basic science investigators affiliated with 
each center. Thus, the current level of interest and activity in 
arthroscopy at the MACs bodes well for the future develop- 
ment of arthroscopy as a tool for research, diagnosis, and 
therapy in rheumatology. 
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Opinions from the research centers surveyed may 
not concur with those from the community of practicing 
rheumatologists, making it inappropriate to extrapolate our 
specific conclusions beyond the group surveyed. Neverthe- 
less, implications of these survey data do extend beyond the 
MACs. We are aware of several other major academic 
rheumatology programs not affiliated with MACs that also 
have ongoing arthroscopy programs in which the utility of this 
technique is being actively explored. The ACR demonstrated 
its support of arthroscopy in 1992 by sponsoring 3 introductory 
courses for rheumatologists interested in the procedure (4). 
Further, Malawista has indicated that the ACR should first 
actively seek to determine the role that arthroscopy may fill as 
a clinical tool, then support the uses of arthroscopy that can be 
shown, with scientific rigor, to be appropriate (5).  Thus, the 
approach being taken toward arthroscopy in rheumatology by 
the discipline’s leading academic centers (MACs and others) 
and primary professional organization (the ACR) defines a path 
by which legitimate uses of arthroscopy will be well established 
before the procedure is recommended as an important tool for 
rheumatologic practice. 
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